Alliança withdraws Brazil filing for Meddi deal after controlling shareholder’s exit
By Maria Júlia Baumert ( February 25, 2026, 19:07 GMT | Comment) -- A sudden and complex restructuring of Alliança Saúde’s ownership has derailed the company’s merger‑control process in Brazil for buying Grupo Meddi. While the authority signaled that the acquisition must be notified again if pursued in the future, Alliança has been careful to say there's no commitment to resubmit the deal –– a message embedded in its communications to the Securities and Exchange Commission of Brazil.A sudden and complex restructuring of Alliança Saúde’s ownership has derailed the company’s merger‑control process in Brazil for buying Grupo Meddi. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.